Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.

Rammensee HG, Gouttefangeas C, Heidu S, Klein R, Preuß B, Walz JS, Nelde A, Haen SP, Reth M, Yang J, Tabatabai G, Bösmüller H, Hoffmann H, Schindler M, Planz O, Wiesmüller KH, Löffler MW

Open source

DOI
10.3390/vaccines9050428
Published
2021 Apr 24
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines9050428,
  title = {Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.},
  author = {Rammensee HG and Gouttefangeas C and Heidu S and Klein R and Preuß B and Walz JS and Nelde A and Haen SP and Reth M and Yang J and Tabatabai G and Bösmüller H and Hoffmann H and Schindler M and Planz O and Wiesmüller KH and Löffler MW},
  year = {2021},
  journal = {Vaccines},
  doi = {10.3390/vaccines9050428},
  url = {https://doi.org/10.3390/vaccines9050428}
}

RIS

TY  - JOUR
TI  - Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
AU  - Rammensee HG
AU  - Gouttefangeas C
AU  - Heidu S
AU  - Klein R
AU  - Preuß B
AU  - Walz JS
AU  - Nelde A
AU  - Haen SP
AU  - Reth M
AU  - Yang J
AU  - Tabatabai G
AU  - Bösmüller H
AU  - Hoffmann H
AU  - Schindler M
AU  - Planz O
AU  - Wiesmüller KH
AU  - Löffler MW
PY  - 2021
JO  - Vaccines
DO  - 10.3390/vaccines9050428
UR  - https://doi.org/10.3390/vaccines9050428
ER  -

APA

HG, R., C, G., S, H., R, K., B, P., JS, W., A, N., SP, H., M, R., J, Y., G, T., H, B., H, H., M, S., O, P., KH, W., & MW, L. (2021). Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.. Vaccines. https://doi.org/10.3390/vaccines9050428

Source records